The emergence of advanced therapy medicinal products (ATMPs), a disruptive class of
health technologies, is generating important challenges in terms of value assessment and …

Advanced therapy medicinal products (ATMPs) are a heterogeneous class of medicinal
products that by offering the potential of cure represent a paradigm shift in the approach of …

Background Advanced therapy medicinal products (ATMPs) are beginning to reach
European markets, and questions are being asked about their value for patients and how …

Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some
cases, hold great potential for patients without an effective current therapeutic approach but …

Advanced therapy medicinal products (ATMPs) are a dynamic and current topic for
healthcare systems, with new products progressing to market at an increasing rate. ATMPs …

Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Background Advanced therapy medicinal products (ATMPs) are innovative therapies likely
associated with high prices. Payers need guidance to create a balance between ensuring …

Value-based pricing (VBP) is well established in markets for common goods and services,
but wide consensus on VBP for pharmaceuticals is lacking. In principle, VBP implies that …

Recent advances in biomedicine are opening the door to new approaches, and treatment
and prevention are being transformed by novel medicines based on genetic engineering …

Background Advanced therapy medicinal products (ATMPs) represent an important
cornerstone for innovation in healthcare. However, uncertainty on the value, the high …